Free Trial
NASDAQ:LFMD

LifeMD (LFMD) Stock Price, News & Analysis

$7.03
+0.07 (+1.01%)
(As of 07/26/2024 ET)
Today's Range
$6.90
$7.14
50-Day Range
$5.82
$8.50
52-Week Range
$3.45
$12.88
Volume
506,649 shs
Average Volume
856,227 shs
Market Capitalization
$293.55 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$12.17

LifeMD MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
73.1% Upside
$12.17 Price Target
Short Interest
Bearish
12.05% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.97mentions of LifeMD in the last 14 days
Based on 4 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.25) to $0.31 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.55 out of 5 stars

Medical Sector

772nd out of 936 stocks

Offices & Clinics Of Medical Doctors Industry

7th out of 8 stocks

LFMD stock logo

About LifeMD Stock (NASDAQ:LFMD)

LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies. It also provides LifeMD PC, a direct-to-consumer virtual primary care which includes 24/7 access to a provider for their primary care, urgent care, and chronic care needs; and offers virtual consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, and more. In addition, the company offers PDFSimpli, an online software as a service platform that allows users to create, edit, convert, sign, and share PDF documents; ResumeBuild which provides digital resume and cover letter services; SignSimpli, a digital signature platform; and LegalSimpli, a provider of legal forms for consumers and small businesses. It sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was incorporated in 1994 and is headquartered in New York, New York.

LFMD Stock Price History

LFMD Stock News Headlines

Mature African American general practitioner recommending pills to online sick male patient on screen of laptop during consultation
Can the New CEO Revive This Struggling Telehealth Stock? (LFMD)
Virtual healthcare provider Teladoc Health Inc. (NYSE: TDOC) stock is trading down 57.8% year-to-date (YTD). The collapse occurred after reporting Q4 2023
3 Overlooked Telehealth Stocks Poised for a Comeback
Rare signal predicts 50% market drop - before election
The market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED will cut rates any day now. But there's one indicator that's flashing a BIG warning sign to investors.
LifeMD Set to Join the Russell 3000 Index
Rare signal predicts 50% market drop - before election
The market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED will cut rates any day now. But there's one indicator that's flashing a BIG warning sign to investors.
See More Headlines
Receive LFMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LifeMD and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/08/2024
Today
7/26/2024
Next Earnings (Estimated)
8/14/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Offices & clinics of medical doctors
Sub-Industry
Healthcare
Current Symbol
NASDAQ:LFMD
Fax
N/A
Employees
230
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$12.17
High Stock Price Target
$15.00
Low Stock Price Target
$10.00
Potential Upside/Downside
+73.1%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
6 Analysts

Profitability

Net Income
$-20,600,000.00
Pretax Margin
-12.60%

Debt

Sales & Book Value

Annual Sales
$163.56 million
Book Value
$0.15 per share

Miscellaneous

Free Float
33,869,000
Market Cap
$293.55 million
Optionable
Optionable
Beta
1.24
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

  • Mr. Justin SchreiberMr. Justin Schreiber (Age 41)
    Chairman & CEO
    Comp: $255k
  • Mr. Marc Benathen (Age 43)
    Chief Financial Officer
    Comp: $378.75k
  • Mr. Eric H. Yecies (Age 46)
    Chief Legal Officer, General Counsel & Secretary
    Comp: $332k
  • Ms. Maria E. Stan CPA (Age 49)
    Controller & Principal Accounting Officer
  • Mr. Dennis Wijnker (Age 48)
    Chief Technology Officer
  • Mr. Shane Biffar
    Chief Compliance Officer & Deputy General Counsel
  • Ms. Jessica Friedeman (Age 40)
    Chief Marketing Officer
  • Mr. Stefan GalluppiMr. Stefan Galluppi (Age 37)
    Chief Innovation Officer
    Comp: $165k
  • Mr. Nicholas P. Alvarez (Age 42)
    Chief Acquisition Officer & Head of Customer Acquisition
    Comp: $141.11k
  • Mr. Varun Pathak
    Chief Software Engineer & Co-Founder of PDF Simpli

LFMD Stock Analysis - Frequently Asked Questions

How have LFMD shares performed this year?

LifeMD's stock was trading at $8.29 at the beginning of the year. Since then, LFMD stock has decreased by 15.2% and is now trading at $7.03.
View the best growth stocks for 2024 here
.

How were LifeMD's earnings last quarter?

LifeMD, Inc. (NASDAQ:LFMD) issued its earnings results on Wednesday, May, 8th. The company reported ($0.19) earnings per share for the quarter, missing analysts' consensus estimates of ($0.13) by $0.06. The firm had revenue of $44.14 million for the quarter, compared to analysts' expectations of $42.66 million.

Who are LifeMD's major shareholders?

Top institutional investors of LifeMD include Bank of New York Mellon Corp (0.56%) and Calamos Advisors LLC (0.14%). Insiders that own company stock include Justin Schreiber, Happy David Walters, Bertrand Velge, Naveen Bhatia, Nicholas P Alvarez, Eric Harold Yecies, Stefan Galluppi, Joseph Ditrolio, Marc David Benathen and Corey Deutsch.
View institutional ownership trends
.

How do I buy shares of LifeMD?

Shares of LFMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:LFMD) was last updated on 7/26/2024 by MarketBeat.com Staff

From Our Partners